Stopping a GLP-1 before surgery: what the anesthesia guidance actually says (2026)

The one-sentence version

If you take a GLP-1 (semaglutide, tirzepatide, liraglutide) and have surgery or a procedure with anesthesia coming up, tell the surgical and anesthesia teams at the pre-op visit — the decision about whether and how long to hold your dose is theirs to make, and it has shifted from a rigid rule toward an individualized one.

Why anesthesiologists care about a weight-loss drug

The mechanism that makes GLP-1 medications work is the same one that creates the surgical concern. These drugs slow gastric emptying, so the stomach releases its contents into the intestine more gradually. That blunts post-meal glucose spikes and prolongs fullness — the therapeutic point — but it also means the stomach may not be empty after the standard pre-operative fasting window that assumes normal emptying [1][3].

Anesthesia suppresses the reflexes that normally keep stomach contents out of the airway. If the stomach still holds food or fluid when you go under, those contents can be regurgitated and inhaled into the lungs. This is pulmonary aspiration: uncommon, but capable of causing pneumonia, airway injury, or worse. Case reports of retained gastric contents in fasted patients on GLP-1s are what prompted anesthesiology societies to act [1][2].

What the 2023 ASA guidance said

In June 2023 the American Society of Anesthesiologists issued consensus-based guidance — the first formal statement on the problem. Its practical core was simple and conservative [2]:

Hold once-weekly GLP-1 medications (semaglutide as Ozempic or Wegovy, tirzepatide as Mounjaro or Zepbound) for one week before an elective procedure requiring anesthesia or deep sedation. Hold once-daily GLP-1 medications (such as liraglutide) on the day of the procedure. If GI symptoms like nausea, bloating, or a sense of fullness are present on the day of surgery, treat the case as higher risk regardless of when the last dose was taken.

This was a reasonable starting point, but a blanket one-week hold is not free: for someone using a GLP-1 for diabetes, a skipped week can worsen glucose control, and stopping and restarting can reset the nausea curve at the next dose. Clinicians pushed for something more nuanced.

What changed in 2024: from a rule to a risk assessment

By late 2024 the evidence had matured, and a review in Anesthesiology reframed the approach around individualized risk rather than a single stop-everyone rule [1]. The shift matters because the aspiration risk is not identical for every patient on every dose.

Three practical tools came out of the update. First, a clear-liquid diet for a defined window before the procedure (rather than a full fast on solid-food timing) reduces the volume of retained gastric contents. Second, point-of-care gastric ultrasound lets the anesthesia team look directly at whether the stomach is empty when the dose timing could not be changed — turning a guess into a measurement. Third, when the stomach cannot be confirmed empty, the team can proceed safely by treating the patient as a 'full stomach' and using a rapid-sequence induction technique instead of cancelling [1].

The direction of travel is clear: the question is no longer only 'did you stop a week ago?' but 'what is your actual aspiration risk today, and how do we manage it?' That is a better fit for the many people who take these drugs and need timely procedures.

Your pre-op checklist

The single most important action is disclosure. Everything else follows from the surgical and anesthesia teams knowing you are on a GLP-1 — and knowing it at the pre-op visit, in time to plan, not on the morning of the procedure. Name the specific drug, the dose, and the date of your most recent dose, because the anesthesia team cares more about when you last took it than about the drug's long half-life.

From there, follow the instructions your team gives you exactly: whether to hold the dose and for how long, whether to switch to a clear-liquid diet for a defined window beforehand, and how to manage insulin or other diabetes medications if you use them. Do not stop other prescriptions on your own — some, like certain blood-pressure and cardiac drugs, should be continued right up to surgery. If any GI symptoms (nausea, bloating, a full feeling) are present the morning of the procedure, say so before you go under; that alone can change how the team manages your airway.

What if you didn't stop it in time

Not stopping is not an automatic cancellation. The 2024 evidence-based approach gives the anesthesia team tools to proceed safely: they can perform a bedside gastric ultrasound to check whether your stomach is actually empty, treat you as a 'full stomach' and use a rapid-sequence induction technique that protects the airway, or, only if the risk is genuinely high, reschedule. The dangerous move is not disclosing it — a team that knows can manage the risk; a team caught off guard cannot [1].

So if you realize on the day that you took your dose too recently, tell them rather than staying quiet out of worry that the procedure will be scrapped. Honesty gives them the chance to keep you safe and, often, to go ahead anyway.

Emergency surgery, colonoscopy, and other situations

In an emergency there is no time to hold a dose, so the anesthesia team simply assumes a full stomach and takes airway precautions accordingly — another reason the individualized approach matters more than a rigid stop rule. For scheduled endoscopy, the concern is twofold: aspiration risk plus the practical problem that retained stomach contents can obscure the view or force an upper endoscopy to be aborted, so the same hold discussion applies [1].

The common thread across all of these is that the GLP-1 rarely dictates whether a procedure can happen; it dictates how the team prepares. That is a manageable logistics problem when it is known in advance, which loops back to the one rule that never changes: tell them.

The bottom line

GLP-1 drugs are not a reason to avoid needed surgery, and the field has moved past the fear-driven blanket-cancel reflex toward individualized risk assessment. The safe path is boringly simple: name the medication and your most recent dose at the pre-op visit, follow the fasting and clear-liquid instructions your team gives you, and let the anesthesiologist make the hold-or-manage call. Concealing it is the only choice that is clearly wrong [1][2].